Sculptor Capital LP
"13F equity value" = market value of this filer's US-listed long equity positions only. It excludes cash, bonds, non-US and short positions, so it understates a fund's true assets under management — often by a lot.
13F holdings are disclosed ~45 days after quarter-end, and they never reveal when within the quarter a fund actually bought. So any 13F-based summary is structurally late and blurred — this applies to every fund, including this one.
We backtested copying it anyway. Buying this fund's new positions the day each filing went public, over 32 quarters, returned +3.1% per quarter — versus +2.7% per quarter from simply owning every 13F stock. It beat that baseline in only 53.1% of quarters (excess t = 0.69, not statistically significant). Its filings tell you what it bought — not what you should buy.
Quarterly compounding, invested quarters only · entry 47 days after quarter-end (when 13F data becomes public)
Top 20 holdings of 290 · 2026 Q1
| Ticker | Value | Weight | QoQ |
|---|---|---|---|
| LITE | $584M | | HOLD |
| WDC | $502M | | TRIM |
| LITE | $470M | | HOLD |
| LITE | $400M | | TRIM |
| FWONK | $354M | | TRIM |
| SHC | $311M | | ADD |
| GMED | $263M | | HOLD |
| KVUE | $222M | | HOLD |
| NSC | $189M | | ADD |
| MKSI | $182M | | NEW |
| LYV | $175M | | ADD |
| ECHO | $146M | | ADD |
| ECHO | $136M | | ADD |
| NVDA | $128M | | TRIM |
| BRKR | $118M | | ADD |
| BABA | $115M | | ADD |
| TSM | $109M | | ADD |
| BAC | $109M | | ADD |
| VIK | $105M | | TRIM |
| AMAT | $102M | | NEW |
QoQ vs previous quarter's share count · NEW = new position · ADD/TRIM = ±2% shares · HOLD = unchanged.
New positions in 2026 Q1
Method & Limitations
Method: a "new position" = held this quarter, absent last quarter (options excluded; stocks with <50 prior holders excluded to filter spin-off artifacts). Entry 47 days after quarter-end — the first day the public could act on the filing. Benchmark = equal-weighted universe of all 13F-held stocks. Limitations: quarterly snapshots can't see intra-quarter trades; survivorship bias — funds that shut down are absent, which flatters the sample. Statistics, not advice.